Updates in Atopic Dermatitis

1-6 of 6

• 

  RestartResume

   Clinical Data on Switching to Upadacitinib

  RestartResume

   Clinical Data on Switching to Upadacitinib

  Updates in Atopic Dermatitis

   Clinical Data on Switching to Upadacitinib

  Christopher Bunick, MD, PhD, FAAD

  Christopher Bunick, MD, PhD, FAAD

• 

  RestartResume

  Evaluating Lebrikizumab in Pigmented Skin

  RestartResume

  Evaluating Lebrikizumab in Pigmented Skin

  Updates in Atopic Dermatitis

  Evaluating Lebrikizumab in Pigmented Skin

  Andrew F. Alexis, MD, MPH

  Andrew F. Alexis, MD, MPH

• 

  RestartResume

  Anti-OX40 Ligand Antibody Trials

  RestartResume

  Anti-OX40 Ligand Antibody Trials

  Updates in Atopic Dermatitis

  Anti-OX40 Ligand Antibody Trials

  Stephan Weidinger, MD, PhD

  Stephan Weidinger, MD, PhD

• 

  RestartResume

  Chronic Hand Eczema

  RestartResume

  Chronic Hand Eczema

  Updates in Atopic Dermatitis

  Chronic Hand Eczema

  Raj Chovatiya, MD, PhD, MSCI, FAAD

  Raj Chovatiya, MD, PhD, MSCI, FAAD

• 

  RestartResume

  Understanding Disparities in AD

  RestartResume

  Understanding Disparities in AD

  Updates in Atopic Dermatitis

  Understanding Disparities in AD

  Raj Chovatiya, MD, PhD, MSCI, FAAD

  Raj Chovatiya, MD, PhD, MSCI, FAAD

• 

  RestartResume

  Eczema Awareness Month

  RestartResume

  Eczema Awareness Month

  Updates in Atopic Dermatitis

  Eczema Awareness Month

  Peter A. Lio, MD

  Peter A. Lio, MD